These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 8692670

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma].
    Tateishi H, Hasuike Y, Kinuta M, Furukawa J, Takata N, Maruyama H, Oi H, Yayoi E, Okamura J.
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903
    [Abstract] [Full Text] [Related]

  • 7. [A patient with HCC successfully treated by ethanol injection therapy with etoposide].
    Sakon M, Kishimoto S, Aoki T, Okuyama M, Shimizu J, Yamada T, Higaki N, Taniguchi K, Takeda H, Sugimoto K, Dohno K, Osato H, Umeshita K, Gotoh M, Monden M.
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1585-7. PubMed ID: 8854812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous ethanol injection therapy for hepatocellular carcinoma: validity of MR imaging in the evaluation of treatment effect.
    Usui H, Itai Y.
    Radiat Med; 1995 Dec; 13(3):103-8. PubMed ID: 7569000
    [Abstract] [Full Text] [Related]

  • 15. [Combined therapy with transcatheter chemo-embolization and percutaneous ethanol injection].
    Nakamura H, Hashimoto T, Suyama Y, Akaji H, Inoue K, Sawada S.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1740-3. PubMed ID: 2167646
    [Abstract] [Full Text] [Related]

  • 16. MR imaging of the liver before and after transcatheter hepatic chemo-embolization for hepatocellular carcinoma.
    Yoshioka H, Nakagawa K, Shindou H, Ono Y, Kawakami A, Mabuchi N, Arita S, Fujii K, Hamada T, Ishida O.
    Acta Radiol; 1990 Jan; 31(1):63-7. PubMed ID: 2160264
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
    Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, Okamura A, Inoue K.
    Cancer; 1999 Apr 15; 85(8):1694-702. PubMed ID: 10223562
    [Abstract] [Full Text] [Related]

  • 20. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep 15; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.